Clinical Trial Update: Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating androgen ablation therapy with or without Niraparib after radiation therapy for high-risk localized or locally advanced pros…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Androgen Ablation Therapy
• Niraparib (Niraparib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Prostate Carcinoma, Stage IIC Prostate Cancer AJCC v8 | Phase 2 | Status: RECRUITING